1. Charles Fettinger Charles Fettinger United States says:

    Not only is antibody response not correlated to positive outcomes for many groups of Covid-19 patients, the durability of antibodies is the weaker as age and other correlated factors increase.

    Then there the issue of variants using older variant antibodies to escape immune response.  

    I am very skeptical of this suggestion from this article and am concerned that it is just a push to lower inventory of the mRNA treatment.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.